Professional
Added to YB: 2024-11-01
Pitch date: 2024-10-30
EXAI [neutral]
Exscientia plc
-4.91%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs.
Market Cap
$499.8M
Pitch Price
$5.09
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.87
P/E
-3.22
EV/Sales
16.07
Sector
Biotechnology
Category
growth
Stock Sonar - Exscientia (NAS:EXAI)
EXAI pass: UK AI drug discovery co partnering w/ BMS & Sanofi. $100-200M annual cash burn w/ $400M cash. Likely future dilution w/ mixed shelf offering. High P/S of 25x. Liquidity concerns despite commercial progress. Streamlines compound design/testing.
Read full article (1 min)